ClinConnect ClinConnect Logo
Search / Trial NCT05530863

Behavioral Relaxation Approaches for Insomnia in Pregnant Patients

Launched by UNIVERSITY OF PENNSYLVANIA · Sep 2, 2022

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This is a randomized, 60-day research study that is evaluating the effect of a simplified behavioral relaxation intervention in pregnant and postpartum patients aimed to improve their insomnia symptoms. The investigators will be enrolling a total of 20 patients who indicate self-reported insomnia symptoms.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age between 18 and 55
  • In second or third trimester of pregnancy (Gestation weeks 18-32)
  • Able to speak, read and write fluent English
  • Has regular access to a smartphone and/or smart tablet
  • sleep onset latency (SOL) or nocturnal awakening need be 30 min or more for ≥3 nights/week, must persist for at least 1 month
  • Exclusion Criteria:
  • Participants with fixed night shift work between midnight and 5 am, or rotating work schedules requiring night shifts during the study period.
  • Medical or other factors that, in the opinion of the study research team, would interfere with their ability to participate in the intervention (such as inability to participate in the ART due to blindness)

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Philadelphia, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Nalaka Gooneratne, MD

Principal Investigator

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials